Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Novo Seeds
Deal Size : $62.2 million
Deal Type : Series A Financing
Details : The new financing, which is the largest Series A financing for a Danish biotech company to develop Antibody drug conjugate, will be used to establish a pipeline of ADCs directed at novel cancer targets and to bring the lead program targeting uPARAP/Endo1...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 29, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Novo Seeds
Deal Size : $62.2 million
Deal Type : Series A Financing